Febrile neutropenia (FN), defined by grade 4 neutropenia and fever greater than 38.0° C, is one of the most dose-limiting toxicities of cancer chemotherapy, noted Gary Lyman, MD, MPH, the senior
FEBRUARY 19, 2019
Better Risk Modeling for Febrile Neutropenia
Nearly 120,000 adults and children are hospitalized annually with neutropenia caused by cancer chemotherapy, at a cost of nearly $3 billion, according to the CDC (Journal of Oncology Practice 2017;13(6):e552–e561). Can prophylaxis be the next big breakthrough in managing these patients?”